About this Journal Submit a Manuscript Table of Contents
Stroke Research and Treatment
Volume 2011 (2011), Article ID 615218, 7 pages
Review Article

Fabry Disease and Early Stroke

1Department of Medical Endocrinology and Metabolism, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
2Department of Medical Endocrinology, PE 2132, National University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark

Received 19 October 2010; Revised 11 March 2011; Accepted 11 March 2011

Academic Editor: Turgut Tatlisumak

Copyright © 2011 U. Feldt-Rasmussen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Rossella Parini, and Sandro Feriozzi, “Females and children with Anderson-Fabry disease: diagnosis, monitoring, benefits of enzyme replacement therapy (ERT) and considerations on timing of starting ERT,” Expert Opinion on Orphan Drugs, vol. 1, no. 4, pp. 315–330, 2013. View at Publisher · View at Google Scholar
  • Antonino Tuttolomondo, “Anderson Fabry Disease: A Multiorgan Metabolic Disease Susceptible of Treatment,” Current Pharmaceutical Design, vol. 19, no. 33, pp. 5972–5973, 2013. View at Publisher · View at Google Scholar
  • Nurcan Ueceyler, Gyoergy A. Homola, Hans Guerrero Gonzalez, Daniela Kramer, Christoph Wanner, Frank Weidemann, Laszlo Solymosi, and Claudia Sommer, “Increased Arterial Diameters in the Posterior Cerebral Circulation in Men with Fabry Disease,” Plos One, vol. 9, no. 1, 2014. View at Publisher · View at Google Scholar